The renal failure outside diabetiqur nephropathy in type 2 diabetics.

被引:0
|
作者
Khochtali, I. [1 ]
Baba, A. [1 ]
Hamza, N. [1 ]
Kacem, M. [1 ]
Marmouch, H. [1 ]
Mahjoub, S. [1 ]
机构
[1] CHU Monastir, Serv Endocrinol Med, Interne CHU Monastir, Monastir 5000, Tunisia
关键词
D O I
10.1016/S1262-3636(10)70267-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:A67 / A67
页数:1
相关论文
共 50 条
  • [31] Use of sodium-glucose cotrasporter 2 inhibitors in type 2 diabetics. Experience in 77 patients
    Contreras, Alvaro
    Grassi, Bruno
    Alfaro, Daniela
    Gonzalez, Felipe
    Ortega, Valeska
    REVISTA MEDICA DE CHILE, 2019, 147 (09) : 1095 - 1100
  • [32] Cardiovascular risk profile of screen detected Type 2 diabetics. The ADDITION-Netherlands study
    Janssen, PGH
    Gorter, KJ
    Stolk, RP
    van Hessen, PAW
    Rutten, GEH
    DIABETOLOGIA, 2004, 47 : A117 - A117
  • [33] Rosiglitazone reduces plasma insulin & its precursors while decreasing glycaemia in type 2 diabetics.
    Jones, NP
    Charbonnel, B
    Lönnqvist, F
    Owen, S
    Patwardhan, R
    DIABETOLOGIA, 1999, 42 : A229 - A229
  • [34] Proteome analysis of serum from type 2 diabetics with nephropathy
    Kim, Hyun-Jung
    Cho, Eun-Hee
    Yoo, Ji-Hye
    Kim, Pan-Kyeom
    Shin, Jun-Seop
    Kim, Mi-Ryung
    Kim, Chan-Wha
    JOURNAL OF PROTEOME RESEARCH, 2007, 6 (02) : 735 - 743
  • [35] Kidney/Pancreas Transplant Outcomes among Older Type I Diabetics.
    Huang, E.
    Kuo, H. -T.
    Bunnapradist, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 428 - 428
  • [36] Prevalence and predictive factors of diabetic nephropathy in type 2 diabetics
    Kacem, A.
    Ben Ahmed, I.
    Berriche, O.
    Jamoussi, H.
    Ben Ammar, I.
    Mnif, S.
    Blouza, S.
    DIABETES & METABOLISM, 2008, 34 : A83 - A83
  • [37] Longitudinal expression profiling and analysis of exercise-responsive genes in type-2 diabetics.
    Hittel, DS
    Kraus, WF
    Hoffman, EP
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 475 - 475
  • [38] Effect of insulin resistance (IR) and obesity on lipids and lipoproteins in healthy relatives of type 2 diabetics.
    Ryder, E
    Campos, G
    Fernandez, V
    Valbuena, H
    Gomez, ME
    Raleigh, X
    FASEB JOURNAL, 2000, 14 (08): : A1372 - A1372
  • [39] Detection of myocardial dysfunction in subclinical speckle tracking imaging in a population of asymptomatic type 2 diabetics.
    Ernande, L.
    Bergerot, C.
    Rietzschel, E. R.
    de Buyzere, M.
    Schnell, F.
    Groisne, L.
    Ovize, M.
    Moulin, P.
    Gillebert, T. C.
    Derumeaux, G.
    DIABETES & METABOLISM, 2010, 36 : A1 - A1
  • [40] Prevalence of impaired diurnal variation in asymptomatic, normotensive type II diabetics.
    Kidambi, S
    Sung, BH
    Shah, K
    Vallabhan, T
    Wilson, MF
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 74A - 74A